Roivant Sciences Ltd.

NasdaqGS:ROIV

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

Location

United Kingdom

Market Cap

USD 7.55 B

Share Price

USD 11.11

Avg Daily Volume

6,663,046

Change (1 day)

0.27%

Change (1 year)

3.64%

Change (YTD)

-6.09%

Roivant Sciences Ltd. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 76.19 M

Roivant Sciences Ltd. Revenue is USD 76.19 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -51.87% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Roivant Sciences Ltd. Revenue for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 158.30 M.
Roivant Sciences Ltd. Revenue for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 29.95 M.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

NasdaqGS: ROIV

Roivant Sciences Ltd.

CEO	Mr. Matthew Gline
IPO Date	Dec. 8, 2020
Location	United Kingdom
Headquarters	11-12 St. James's Square
Employees	908
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💄 Cosmetics

Description

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Similar companies

Novo Nordisk A/S

USD 74.96

-2.66%

AbbVie Inc.

USD 185.48

-2.82%

Roche Holding AG

USD 340.74

-0.81%

Abbott Laboratories

USD 132.28

-1.29%

Novartis AG

USD 116.89

-1.07%

AstraZeneca PLC

USD 143.28

-2.39%

Merck & Co., Inc.

USD 78.28

-3.31%

Amgen Inc.

USD 290.05

-1.86%

Pfizer Inc.

USD 24.00

-1.64%

Gilead Sciences, Inc.

USD 108.00

-2.55%

Sanofi

USD 97.40

-1.88%

Vertex Pharmaceuticals Incorporated

USD 441.99

-1.98%

Bristol-Myers Squibb Company

USD 47.23

-2.94%

Chugai Pharmaceutical Co., Ltd.

USD 50.33

-0.98%

GSK plc

USD 19.89

-1.33%

CSL Limited

USD 155.93

0.65%

MERCK Kommanditgesellschaft auf Aktien

USD 128.68

-2.90%

Regeneron Pharmaceuticals, Inc.

USD 508.86

-2.64%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.21

-3.63%

Takeda Pharmaceutical Company Limited

USD 29.91

-0.01%

Alnylam Pharmaceuticals, Inc.

USD 308.71

-0.02%

UCB SA

USD 181.55

-3.02%

GE HealthCare Technologies Inc.

USD 71.14

-2.36%

Bayer AG

USD 31.18

-2.20%

WuXi AppTec Co., Ltd.

USD 9.51

-2.39%

Celltrion, Inc.

USD 117.92

1.23%

Laboratory Corporation of America Holdings

USD 259.45

-1.71%

Hansoh Pharmaceutical Group Company Limited

USD 3.61

0.03%

Royalty Pharma plc

USD 34.56

-1.54%

Insmed Incorporated

USD 100.28

-1.29%

Biogen Inc.

USD 126.56

-3.42%

Astellas Pharma Inc.

USD 9.52

-0.01%

Innovent Biologics, Inc.

USD 9.89

0.68%

Summit Therapeutics Inc.

USD 19.85

-0.50%

Shionogi & Co., Ltd.

USD 17.26

0.45%

Genmab A/S

USD 221.34

-2.90%

Torrent Pharmaceuticals Limited

USD 37.58

-0.14%

Neurocrine Biosciences, Inc.

USD 124.88

-0.10%

Exelixis, Inc.

USD 41.35

-0.95%

Mankind Pharma Limited

USD 27.23

0.10%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.93

0.69%

Akeso, Inc.

USD 11.92

-0.45%

BioMarin Pharmaceutical Inc.

USD 55.00

-2.21%

Ascendis Pharma A/S

USD 172.90

-2.71%

Lupin Limited

USD 22.67

0.88%

Swedish Orphan Biovitrum AB (publ)

USD 29.57

-2.43%

Huadong Medicine Co., Ltd

USD 5.83

-4.14%

Ipsen S.A.

USD 117.89

-1.74%

Kyowa Kirin Co., Ltd.

USD 17.14

0.37%

StockViz Staff

June 18, 2025

Any question? Send us an email